Critical Care in Human Immunodeficiency Virus-Infected Patients

被引:17
|
作者
Akguen, Kathleen M. [1 ,2 ]
Miller, Robert F. [3 ,4 ]
机构
[1] VA Connecticut, Dept Med, Sect Pulm Crit Care & Sleep, West Haven, CT USA
[2] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep, New Haven, CT USA
[3] UCL, Res Dept Infect & Populat Hlth, London, England
[4] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England
关键词
HIV; antiretroviral therapy; outcomes; opportunistic infections; PNEUMOCYSTIS-CARINII-PNEUMONIA; ACTIVE ANTIRETROVIRAL THERAPY; RECONSTITUTION INFLAMMATORY SYNDROME; ACUTE RESPIRATORY-FAILURE; ACUTE KIDNEY INJURY; LONG-TERM SURVIVAL; INTENSIVE-CARE; HIV-INFECTION; BACTERIAL PNEUMONIA; HOSPITALIZED-PATIENTS;
D O I
10.1055/s-0036-1572561
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Intensive care unit (ICU) survival has been improved significantly for HIV-infected patients since the advent of antiretroviral therapy (ART). Non-AIDS conditions account for the majority of ICU admission diagnoses in areas with access to ART. However, opportunistic infections such as Pneumocystis jirovecii pneumonia still account for a significant proportion of ICU admissions, particularly in newly diagnosed HIV-infected patients, and are associated with increased ICU mortality. We discuss risk factors and outcomes for HIV-infected admitted to the ICU in the current ART era. We review the changing patterns in ICU admission diagnoses over time and how common ICU conditions are managed in HIV-infected compared with uninfected patients. We next address issues specific to the care for HIV-infected patients in the ICU, focusing on immune reconstitution inflammatory syndrome, ART continuation or initiation, and some common and potentially life-threatening ART-associated toxicities.
引用
收藏
页码:303 / 317
页数:15
相关论文
共 50 条
  • [1] Critical Crossroads in the Care of Human Immunodeficiency Virus-Infected Persons
    Crum-Cianflone, Nancy
    [J]. CRITICAL CARE MEDICINE, 2013, 41 (06) : 1579 - 1580
  • [2] Current issues in critical care of the human immunodeficiency virus-infected patient
    Morris, A
    Masur, H
    Huang, L
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (01) : 42 - 49
  • [3] Integration of palliative care into primary care for human immunodeficiency virus-infected patients
    Kutzen, HS
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 328 (01): : 37 - 47
  • [4] Lipodystrophy in human immunodeficiency virus-infected patients
    Chen, DL
    Misra, A
    Garg, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11): : 4845 - 4856
  • [5] Hyperhomocysteinemia in human immunodeficiency virus-infected patients
    Duro, M.
    Manso, M. C.
    Rebelo, I
    Medeiros, R.
    Almeida, C.
    [J]. BIOMEDICAL RESEARCH-INDIA, 2016, 27 (02): : 557 - 562
  • [6] MYALGIAS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
    BUSKILA, D
    LANGEVITZ, P
    [J]. AMERICAN JOURNAL OF MEDICINE, 1989, 86 (04): : 510 - 511
  • [7] Hepatitis A in human immunodeficiency virus-infected patients
    Wallace, MR
    Hill, HE
    Tasker, SA
    Miller, LK
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 27 (03) : 651 - 653
  • [8] Care of the human immunodeficiency virus-infected menopausal woman
    Cejtin, Helen Elizabeth
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 207 (02) : 87 - 93
  • [9] BK virus infection in human immunodeficiency virus-infected patients
    J. Ledesma
    P. Muñoz
    D. Garcia de Viedma
    I. Cabrero
    B. Loeches
    P. Montilla
    P. Gijon
    B. Rodriguez-Sanchez
    E. Bouza
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 1531 - 1535
  • [10] BK virus infection in human immunodeficiency virus-infected patients
    Ledesma, J.
    Munoz, P.
    Garcia de Viedma, D.
    Cabrero, I.
    Loeches, B.
    Montilla, P.
    Gijon, P.
    Rodriguez-Sanchez, B.
    Bouza, E.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (07) : 1531 - 1535